1019331-10-2

1019331-10-2 structure

Name: S0859
Chemical Name: 2-chloro-N-[[4-[2-(cyanosulfamoyl)phenyl]phenyl]methyl]-N-[(4-methylphenyl)methyl]benzamide
CAS Number: 1019331-10-2
Molecular Formula: C₂₉H₂₄ClN₃O₃S
Molecular Weight: 530.037
Catalog: Signaling Pathways Membrane Transporter/Ion Channel Na+/HCO3- Cotransporter
Create Date: 2017-07-08 01:14:18
Modify Date: 2024-01-02 14:57:15
S0859, an N-cyanosulphonamide compound, reversibly inhibit NBC-mediated pH(i) recovery (K (i)=1.7 microM, full inhibition at approximately 30 microM). IC50 value:Target: NBCNa(+)-coupled HCO(3)(-) transporters (NBCs) mediate the transport of bicarbonate ions across cell membranes and are thus ubiquitous regulators of intracellular pH. NBC dysregulation is associated with a range of diseases; for instance, NBCn1 is strongly up-regulated in a model of ErbB2-dependent breast cancer, a malignant and widespread cancer with no targeted treatment options, and single-nucleotide polymorphisms in NBCn1 genetically link to breast cancer development and hypertension. Treatment with NBC inhibitor S0859 significantly increased caspase-3 activity and elevated the number of apoptotic EC. S0859 is potentially important for probing the transporter's functional role in heart and other tissues.

Name	2-chloro-N-[[4-[2-(cyanosulfamoyl)phenyl]phenyl]methyl]-N-[(4-methylphenyl)methyl]benzamide
Synonyms	CS-1092 Benzamide, 2-chloro-N-[[2'-[(cyanoamino)sulfonyl][1,1'-biphenyl]-4-yl]methyl]-N-[(4-methylphenyl)methyl]- QCR-54 S-0859 2-Chloro-N-{[2'-(cyanosulfamoyl)-4-biphenylyl]methyl}-N-(4-methylbenzyl)benzamide 2-chloro-N-((2'-(N-cyanosulfamoyl)biphenyl-4-yl)methyl)-N-(4-methylbenzyl)benzamide S0859

Description	S0859, an N-cyanosulphonamide compound, reversibly inhibit NBC-mediated pH(i) recovery (K (i)=1.7 microM, full inhibition at approximately 30 microM). IC50 value:Target: NBCNa(+)-coupled HCO(3)(-) transporters (NBCs) mediate the transport of bicarbonate ions across cell membranes and are thus ubiquitous regulators of intracellular pH. NBC dysregulation is associated with a range of diseases; for instance, NBCn1 is strongly up-regulated in a model of ErbB2-dependent breast cancer, a malignant and widespread cancer with no targeted treatment options, and single-nucleotide polymorphisms in NBCn1 genetically link to breast cancer development and hypertension. Treatment with NBC inhibitor S0859 significantly increased caspase-3 activity and elevated the number of apoptotic EC. S0859 is potentially important for probing the transporter's functional role in heart and other tissues.
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Na+/HCO3- Cotransporter Research Areas >> Cardiovascular Disease
References	[1]. Larsen AM, Krogsgaard-Larsen N, Lauritzen G, et al. Gram-scale solution-phase synthesis of selective sodium bicarbonate co-transport inhibitor S0859: in vitro efficacy studies in breast cancer cells. ChemMedChem. 2012 Oct;7(10):1808-14. [2]. Lauritzen G, Stock CM, Lemaire J, et al. The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2. Cancer Lett. 2012 Apr 28;317(2):172-83. [3]. Kumar S, Flacke JP, Kostin S, et al. SLC4A7 sodium bicarbonate co-transporter controls mitochondrial apoptosis in ischaemic coronary endothelial cells. Cardiovasc Res. 2011 Feb 1;89(2):392-400. [4]. Ch'en FF, Villafuerte FC, Swietach P, et al. S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart. Br J Pharmacol. 2008 Mar;153(5):972-82.

Density	1.3±0.1 g/cm3
Boiling Point	748.5±70.0 °C at 760 mmHg
Molecular Formula	C₂₉H₂₄ClN₃O₃S
Molecular Weight	530.037
Flash Point	406.5±35.7 °C
Exact Mass	529.122681
PSA	98.65000
LogP	5.68
Appearance	white solid
Vapour Pressure	0.0±2.5 mmHg at 25°C
Index of Refraction	1.639
Storage condition	-20℃

Hazard Statements	H413
RIDADR	NONH for all modes of transport

2133476-88-5	1158522-08-7
940364-43-2	134104-43-1
2138248-73-2	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	1375289-11-4